Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients-Reference-Cited by-同舟云学术

Development and validation of LC-MS/MS method for imatinib and norimatinib monitoring by finger-prick DBS in gastrointestinal stromal tumor patients

Published:2019-11-19 Issue:11 Volume:14 Page:e0225225
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Iacuzzi Valentina,Posocco Bianca^ORCID,Zanchetta Martina,Montico Marcella,Marangon Elena,Poetto Ariana Soledad,Buzzo Mauro,Gagno Sara,Buonadonna Angela,Guardascione Michela,Casetta Bruno,Toffoli Giuseppe

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference24 articles.

1. Imatinib compared with interferon and low-dose cytarabine for newly diagnosed chronic-phase chronic myeloid leukemia;IRIS Investigators;N Engl J Med,2003

2. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study;European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group;Lancet Lond Engl,2001

3. A benefit-risk assessment of imatinib in chronic myeloid leukaemia and gastrointestinal stromal tumours;D Wolf;Drug Saf,2009

4. Imatinib plasma levels are correlated with clinical benefit in patients with unresectable/metastatic gastrointestinal stromal tumors;GD Demetri;J Clin Oncol Off J Am Soc Clin Oncol,2009

5. Review of therapeutic drug monitoring of anticancer drugs part two–Targeted therapies;N Widmer;Eur J Cancer,2014

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical control of imatinib in bioanalytical samples using graphene quantum dots sensing;Analytical and Bioanalytical Chemistry;2024-05-25

2. The identification of c-Abl inhibitors as potential agents for Parkinson’s disease: a preliminary in silico approach;Molecular Diversity;2024-01-25

3. Therapeutic drug monitoring and pharmacogenetics to tune imatinib exposure in gastrointestinal stromal tumor patients: hurdles and perspectives for clinical implementation;Pharmacogenomics;2023-12

4. Therapeutic Drug Monitoring of Imatinib and N‐Desmethyl Imatinib in Chronic Myeloid Leukemia Patients Using LC‐MS/MS in a Cohort Study;The Journal of Clinical Pharmacology;2023-09

5. A high-throughput UHPLC-MS/MS method for the determination of eight anti-tumor drugs in plasma;Analytical Biochemistry;2023-09